What is Arbutus Biopharma Corporation's investing cash flow?

Arbutus Biopharma Corporation (ABUS) reported investing cash flow of $2.2M in Q1 2026.

How has Arbutus Biopharma Corporation's investing cash flow changed year-over-year?

Arbutus Biopharma Corporation's investing cash flow decreased by 80.6% year-over-year, from $11.35M to $2.2M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Arbutus Biopharma Corporation ABUS Investing Cash Flow

Investing Cash Flow at other companies

Arrowhead ResearchARWR

-$894.28M-113%

Gilead SciencesGILD

$1.77B+527%

ALN

Alnylam PharmaceuticalsALNY

-$25.54M-122%

AnaptysBio, Inc.ANAB

$34.98M+136%

Avalo TherapeuticsAVTX

$25.51M—

Vir Biotechnology, Inc.VIR

$11.84M-90.7%

Other financials

Income statement

See full

Revenue$179.1M+10,055%

Operating income$168.9M+757%

Net income$169.7M+792%

EPS (diluted)$0.87+769%

Balance sheet

See full

Cash & equivalents$23.7M-36.1%

Total debt$631.0K-46.9%

Total equity$260.2M+229%

Total assets$277.2M+137%

Cash flow

See full

Operating cash flow-$8.1M+39.4%

CapEx--100%

Free cash flow-$4.7M+55.0%

Valuation

See full

Market cap$881.02M+32.6%

Enterprise value$857.94M+36.6%

P/E5.5×—

P/S4.6×-99.1×

Profitability

See full

Operating margin81.7%+42.1pp

Net margin84%+43.4pp

FCF margin-281.5%-119pp

Returns & leverage

See full

Return on equity94.7%+65.1pp

Debt / equity0×0.0×

Current ratio54.3×+48.3×

Where this comes from

Reported directly by Arbutus Biopharma Corporation in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arbutus Biopharma Corporation's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arbutus Biopharma Corporation's investing cash flow?: Arbutus Biopharma Corporation (ABUS) reported investing cash flow of $2.2M in Q1 2026.
How has Arbutus Biopharma Corporation's investing cash flow changed year-over-year?: Arbutus Biopharma Corporation's investing cash flow decreased by 80.6% year-over-year, from $11.35M to $2.2M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.